Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasahara, Y.
Right arrow Articles by Koizumi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasahara, Y.
Right arrow Articles by Koizumi, S.
Related Collections
Right arrow Immunobiology
Right arrow Clinical Trials and Observations
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 September 2001, Vol. 98, No. 6, pp. 1882-1888

IMMUNOBIOLOGY

Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection

Yoshihito Kasahara, Akihiro Yachie, Kenkichi Takei, Chiharu Kanegane, Kanae Okada, Kazuhide Ohta, Hidetoshi Seki, Noboru Igarashi, Keiko Maruhashi, Keita Katayama, Eiji Katoh, Gaku Terao, Yukio Sakiyama, and Shoichi Koizumi

From the Department of Pediatrics, Angiogenesis and Vascular Development, Graduate School of Medical Science, and the Department of Laboratory Sciences and Department of Nursing, School of Health Sciences, Faculty of Medicine, Kanazawa University, Ishikawa, Japan; Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan; Department of Pediatrics, Fukui Saiseikai Hospital, Fukui, Japan; Department of Pediatrics, Fukui Prefectural Hospital, Fukui, Japan; and Department of Human Gene Therapy, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Unusual Epstein-Barr virus (EBV) infection into T or natural killer cells plays a pivotal role in the pathogenesis of acute EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) and chronic active EBV infection (CAEBV). The precise frequency and localization of EBV genome in lymphocyte subpopulations especially within T-cell subpopulations are unclear in these EBV-related disorders. This study analyzed the frequency of EBV-infected cells in circulating lymphocyte subpopulations from 4 patients with acute EBV-HLH and 4 with CAEBV. EBV- encoded small RNA-1 in situ hybridization examination of peripheral blood lymphocytes showed a significantly higher frequency of EBV-infected cells of 1.0% to 13.4% in EBV-HLH and 1.6% to 25.6% in CAEBV, respectively. The patterns of EBV infection in lymphocyte subpopulations were quite different between acute EBV-HLH and CAEBV. EBV infection was predominant in CD8+ T cells in all EBV-HLH patients, whereas the dominant EBV-infected cell populations were non-CD8+ lymphocyte subpopulations in CAEBV patients. Phenotypical analysis revealed that EBV-infected cell populations from both EBV-HLH and CAEBV were activated. There was no predominance of any EBV substrain of latent membrane protein-1, EBV-associated nuclear antigen (EBNA)-1, and EBNA-2 genes between the 2 abnormal EBV-associated disorders, and self-limited acute infectious mononucleosis. These results showing differential virus-cell interactions between acute EBV-HLH and CAEBV indicated different pathogenic mechanisms against EBV infection between the 2 EBV-associated diseases, which accounts for the difference in clinical manifestations between the 2 diseases.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arch DermatolHome page
K. Iwatsuki, M. Satoh, T. Yamamoto, T. Oono, S. Morizane, M. Ohtsuka, Z.-G. Xu, D. Suzuki, and K. Tsuji
Pathogenic link between hydroa vacciniforme and epstein-barr virus-associated hematologic disorders.
Arch Dermatol, May 1, 2006; 142(5): 587 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. Trempat, J. Tabiasco, P. Andre, N. Faumont, F. Meggetto, G. Delsol, R. D. Gascoyne, J.-J. Fournie, E. Vivier, and P. Brousset
Evidence for Early Infection of Nonneoplastic Natural Killer Cells by Epstein-Barr Virus
J. Virol., October 2, 2002; 76(21): 11139 - 11142.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020